HGF and coronary artery disorder: As a part of it, in the present study, we intended to examine a combinatory cell therapy using BM-MSCs and HGF-eMSCs, which we named in situ preconditioning strategy, to promote the therapeutic efficacy of hMSCs for the treatment of ischemic heart disease.